Evidence map›Paper›PMID 32357567›Full record

ArticleCells2020

Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.

Kyoung Mi Sim, Young-Sun Lee, Hee Jin Kim, Chang-Hoon Cho, Gwan-Su Yi, Myung-Jin Park, Eun Mi Hwang, Jae-Yong Park

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Polymodal Control of TMEM16x Channels and Scramblases.International journal of molecular sciences · 2022
    Review
  8. The CaActa pharmaceutica Sinica. B · 2021
    Review
  9. p21-Activated Kinase 1 Promotes Breast TumorigenesisFrontiers in cell and developmental biology · 2021
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kyoung Mi SimSchool of Biosystems and Biomedical Sciences, College of Health Sciences, Korea University, Seoul 02841, Korea.
Young-Sun LeeSchool of Biosystems and Biomedical Sciences, College of Health Sciences, Korea University, Seoul 02841, Korea.
Hee Jin KimSchool of Biosystems and Biomedical Sciences, College of Health Sciences, Korea University, Seoul 02841, Korea.
Chang-Hoon ChoSchool of Biosystems and Biomedical Sciences, College of Health Sciences, Korea University, Seoul 02841, Korea.
Gwan-Su YiDepartment of Bio and Brain Engineering, KAIST, Daejeon 34141, Korea.
Myung-Jin ParkDivision of Radiation Cancer Research, Research Center for Radio-Senescence, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Korea.
Eun Mi HwangCenter for Functional Connectomics, KIST, Seoul 02792, Korea.ORCID 0000-0002-3130-8572
Jae-Yong ParkSchool of Biosystems and Biomedical Sciences, College of Health Sciences, Korea University, Seoul 02841, Korea.ORCID 0000-0001-7698-7890
Korea University · KRKorea Advanced Institute of Science and Technology · KRKorea Institute of Radiological and Medical Sciences · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ANO1, a Ca

Indexed as

Anoctamin-1Biological TransportCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell Line, TumorCell MovementCell ProliferationDisease ProgressionGene ExpressionGene Expression Regulation, NeoplasticGlioblastomaHumansNeoplasm ProteinsANO1 protein, humanAnoctamin-1Calcium-Calmodulin-Dependent Protein Kinase Type 2Neoplasm ProteinsANO1CaMKIIβU251 glioblastoma cellsU87 MG glioblastoma cells

Identifiers

PMID32357567
PMCPMC7290681
OpenAlexW3017479865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.